Showing results (271-280 of 441) with videos related to
Sort By:
Pageof 45
Neuro-Oncology|August 24, 2010
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastomaMark R Gilbert, Javier Gonzalez, Kathy Hunter, et al.Journal for Immunotherapy of Cancer|June 13, 2018
Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapyAmber J Giles, Marsha-Kay N D Hutchinson, Heather M Sonnemann, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed GlioblastomaCaroline Happold, Thierry Gorlia, Olivier Chinot, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variationLuo Wang, Qingyi Wei, Li-E Wang, et al.Oncotarget|May 10, 2014
Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytesKonrad Gabrusiewicz, Dan Liu, Nahir Cortes-Santiago, et al.Neuro-Oncology|March 12, 2015
Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627)Andrew B Lassman, Stephanie L Pugh, Mark R Gilbert, et al.European Journal of Cancer (Oxford, England : 1990)|April 6, 2019
Clinical trial participation of patients with glioblastoma at The University of Texas MD Anderson Cancer CenterRebecca A Harrison, Mark D Anderson, David Cachia, et al.Cancers|January 16, 2020
Inhibition of PP2A with LB-100 Enhances Efficacy of CAR-T Cell Therapy Against GlioblastomaJing Cui, Herui Wang, Rogelio Medina, et al.International Journal of Radiation Oncology, Biology, Physics|February 26, 2013
Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastomaAaron P Brown, Christian L Barney, David R Grosshans, et al.Neuro-Oncology|January 30, 2021
Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825)Jeffrey S Wefel, Terri S Armstrong, Stephanie L Pugh, et al.Pageof 45